| Phase separation kinetics in amorphous solid dispersions upon exposure to water HS Purohit, LS Taylor Molecular pharmaceutics 12 (5), 1623-1635, 2015 | 104 | 2015 |
| Phase behavior of ritonavir amorphous solid dispersions during hydration and dissolution HS Purohit, LS Taylor Pharmaceutical research 34, 2842-2861, 2017 | 102 | 2017 |
| Novel lipid based oral formulation of curcumin: development and optimization by design of experiments approach YB Pawar, H Purohit, GR Valicherla, B Munjal, SV Lale, SB Patel, ... International journal of pharmaceutics 436 (1-2), 617-623, 2012 | 82 | 2012 |
| Miscibility of itraconazole–hydroxypropyl methylcellulose blends: Insights with high resolution analytical methodologies HS Purohit, LS Taylor Molecular pharmaceutics 12 (12), 4542-4553, 2015 | 70 | 2015 |
| Investigating the impact of drug crystallinity in amorphous tacrolimus capsules on pharmacokinetics and bioequivalence using discriminatory in vitro dissolution testing and … HS Purohit, NS Trasi, DD Sun, ECY Chow, H Wen, X Zhang, Y Gao, ... Journal of pharmaceutical sciences 107 (5), 1330-1341, 2018 | 65 | 2018 |
| Insights into nano-and micron-scale phase separation in amorphous solid dispersions using fluorescence-based techniques in combination with solid state nuclear magnetic … HS Purohit, JD Ormes, S Saboo, Y Su, MS Lamm, AKP Mann, LS Taylor Pharmaceutical research 34, 1364-1377, 2017 | 65 | 2017 |
| Dropwise additive manufacturing of pharmaceutical products for amorphous and self emulsifying drug delivery systems E Içten, HS Purohit, C Wallace, A Giridhar, LS Taylor, ZK Nagy, ... International journal of pharmaceutics 524 (1-2), 424-432, 2017 | 50 | 2017 |
| Evaluation of the crystallization tendency of commercially available amorphous tacrolimus formulations exposed to different stress conditions NS Trasi, HS Purohit, LS Taylor Pharmaceutical research 34, 2142-2155, 2017 | 40 | 2017 |
| Non-Sink Dissolution Behavior and Solubility Limit of Commercial Tacrolimus Amorphous Formulations NS Trasi, HS Purohit, H Wen, DD Sun, LS Taylor Journal of Pharmaceutical Sciences 106 (1), 264-272, 2017 | 34 | 2017 |
| Assessing the impact of endogenously derived crystalline drug on the in vivo performance of amorphous formulations HS Purohit, NS Trasi, DJ Osterling, DF Stolarik, GJ Jenkins, W Gao, ... Molecular pharmaceutics 16 (8), 3617-3625, 2019 | 30 | 2019 |
| Release mechanisms of amorphous solid dispersions: role of drug-polymer phase separation and morphology R Yang, GGZ Zhang, DY Zemlyanov, HS Purohit, LS Taylor Journal of Pharmaceutical Sciences 112 (1), 304-317, 2023 | 21 | 2023 |
| Phase separation in surfactant-containing amorphous solid dispersions: Orthogonal analytical methods to probe the effects of surfactants on morphology and phase composition R Yang, GGZ Zhang, K Kjoller, E Dillon, HS Purohit, LS Taylor International Journal of Pharmaceutics 619, 121708, 2022 | 17 | 2022 |
| Dissolution Mechanisms of Amorphous Solid Dispersions: Role of Drug Load and Molecular Interactions A Deac, Q Qi, AS Indulkar, HS Purohit, Y Gao, GGZ Zhang, LS Taylor Molecular Pharmaceutics 20 (1), 722-737, 2022 | 16 | 2022 |
| Drug Release from Surfactant-Containing Amorphous Solid Dispersions: Mechanism and Role of Surfactant in Release Enhancement R Yang, GGZ Zhang, DY Zemlyanov, HS Purohit, LS Taylor Pharmaceutical Research, 1-29, 2023 | 6 | 2023 |
| Detecting Crystallinity in Amorphous Solid Dispersions Using Dissolution Testing: Considerations on Properties of Drug Substance, Drug Product, and Selection of Dissolution Media HS Purohit, GGZ Zhang, Y Gao Journal of Pharmaceutical Sciences 112 (1), 290-303, 2023 | 4 | 2023 |
| Design of a Re-Dispersible High Drug Load Amorphous Formulation HS Oberoi, F Arce, HS Purohit, M Yu, CA Fowler, D Zhou, D Law Journal of Pharmaceutical Sciences 112 (1), 250-263, 2023 | 3 | 2023 |
| Proof-of-concept in developing a 45% drug loaded amorphous nanoparticle formulation HS Purohit, D Zhou, M Yu, M Zaroudi, H Oberoi, ALR López, MS Kelkar, ... Journal of Pharmaceutical Sciences, 2023 | 1 | 2023 |
| Phase Behavior of Amorphous Solid Dispersions during Hydration and Dissolution HS Purohit Purdue University, 2017 | 1 | 2017 |
| Design of Redispersible High-Drug-Load Amorphous Formulations: Impact of Ionic vs Nonionic Surfactants on Processing and Performance M Yu, HS Oberoi, HS Purohit, CA Fowler, D Law Molecular Pharmaceutics, 2023 | | 2023 |
| Limitations in the Pharmacopeial Dissolution Testing of Marketed Tacrolimus Amorphous Solid Dispersions HS Purohit, Y Gao, GG Zhang, D Sun, H Wen, LS Taylor | | |
Lynne TaylorProfessor of Industrial and Physical Pharmacy, Purdue UniversityVerified email at purdue.edu
